TPST Tempest Therapeutics, Inc.: Company Short-Term Debts

Symbol and logo of brand Tempest Therapeutics (TPST)

Tempest Therapeutics production capacities are fully utilized in the creation of oncology drugs using calibrated equipment. Innovative molecules for immune stimulation will ensure premium pricing following regulatory approval. However, high burn rates and dependence on clinical trials create risks. The company's short-term liabilities on the chart reflect borrowing dynamics, and 0.00 shows the current value of the metric.

TPST Tempest Therapeutics Inc Company Short-Term Loans and Borrowings (07/04/2022 - 10/29/2026)

TPST (Tempest Therapeutics Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Tempest Therapeutics, Inc.|TPST - Consensus Target
- company stock capitalization data:
Market Capitalization Tempest Therapeutics, Inc.|TPST - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Tempest Therapeutics|TPST - Accounting Value of Company|Market Cap to Net Assets Ratio tempesttx.com|TPST - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Tempest Therapeutics|TPST - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Tempest Therapeutics|TPST - Company Aggregate Debts|Debt to Book Capitalization Ratio Tempest Therapeutics, Inc.|TPST - Company Long-Term Loans and Borrowings|Company Short-Term Debts Tempest Therapeutics
Analysis of all company metrics:TPST - Tempest Therapeutics, Inc.
Manufactured products of tempesttx.com

This indicator captures the total volume of credit obligations with maturities of up to one year, reflecting the actual liquidity burden absent market volatility. An analysis of short-term balance sheet liabilities allows for an assessment of the cash gap risk for Tempest Therapeutics (TPST), whose financial stability depends critically on the success of costly oncology research and the ability to raise capital for R&D.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Current Liabilities CTOR (Citius Oncology, Inc.)|Amount of Current Liabilities HURA|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Fate Therapeutics Inc (FATE) - Short-Term Debt|WHWK - Company Short-Term Debt|TScan Therapeutics (TCRX) - Company Current Liabilities|championsoncology.com (CSBR) - Company Short-Term Debt|Current Liabilities XBIT (XBiotech)|CVM (CEL-SCI Corp.) - Company Short-Term Debts|Short-Term Debt OS Therapies Inc. OSTX|Company Short-Term Debt Radiopharm Theranostics (RADX)|Short-Term Debt Volume artivabio.com|Adlai Nortye - Company Current Liabilities|Amount of Current Liabilities VERU (verupharma.com)|XLO: Company Current Liabilities|Company Short-Term Loans and Borrowings RENB (Renovaro Inc.)|MURA (muraloncology.com) - Company Current Liabilities|KAPA: Amount of Current Liabilities|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|GDTC: Company Short-Term Loans and Borrowings|Company Short-Term Debts CRIS|APLM - Short-Term Debt|Company Short-Term Debt Tharimmune Corp THAR|Company Short-Term Loans and Borrowings ADVB|Genprex, Inc. - Company Short-Term Debts|CLDI - Company Short-Term Debts|Sunshine Biopharma (SBFM) - Company Short-Term Debt|Current Liabilities XBIO (Xenetic Biosciences, Inc.)|SLRX (Salarius) - Company Short-Term Debts|Short-Term Debt Kitov Pharma PPBT|Company Current Liabilities AONC (American Oncology Network)|Company Short-Term Debts beigene.com (BGNE)|Checkpoint Therapeutics, Inc. - Company Current Liabilities|Amount of Current Liabilities ELEV (Elevation Oncology Inc.)|iCAD Corp - Company Short-Term Debts|Short-Term Debt Volume Ikena Oncology, Inc. IKNA|NTBL: Company Short-Term Debts|Company Current Liabilities Viracta Therapeutics, Inc.|Company Short-Term Debt MorphoSys|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Current Liabilities AAPGV (Ascentage Pharma Group Ltd)